Publication | Closed Access

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial

Ocular DiseaseOphthalmologyEye HealthPlacebo-controlled TrialRin-1 StudyNeurologyMultiple SclerosisMedicine